Antihypertensive effect of caffeic acid and its analogs through dual renin-angiotensin-aldosterone system inhibition

European Journal of Pharmacology

Volumn 730, Issue 1, 2014, Pages 125-132

  Bhullar, Khushwant S ^a   Lassalle Claux, Grégoire ^b   Touaibia, Mohamed ^b   Vasantha Rupasinghe, H P ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b UNIVERSITÉ DE MONCTON   (Canada)

Author keywords

Aldosterone; Angiotensin converting enzyme; Caffeic acid; Hypertension; Polyphenols; Renin

Indexed keywords

ALDOSTERONE; ALISKIREN; CAFFEIC ACID; CAFFEIC ACID DERIVATIVE; CAPTOPRIL; CHLOROGENIC ACID; DIPEPTIDYL CARBOXYPEPTIDASE; QUERCETIN; RENIN; ANTIHYPERTENSIVE AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIHYPERTENSIVE ACTIVITY; ARTICLE; DRUG DETERMINATION; DRUG STRUCTURE; DRUG TARGETING; ENZYME INHIBITION; FIBROBLAST; HORMONE INHIBITION; HUMAN; HUMAN CELL; HYPERTENSION; IC 50; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; TOXICITY TESTING; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOSYNTHESIS; CELL LINE; CHEMISTRY; DRUG EFFECTS; METABOLISM;

ALDOSTERONE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; ANTIHYPERTENSIVE AGENTS; CAFFEIC ACIDS; CELL LINE; FIBROBLASTS; HUMANS; PEPTIDYL-DIPEPTIDASE A; RATS; RENIN; RENIN-ANGIOTENSIN SYSTEM;

EID: 84896551623     PISSN: 00142999     EISSN: 18790712     Source Type: Journal    
DOI: 10.1016/j.ejphar.2014.02.038     Document Type: Article

References (32)

1. L. Actis-Goretta, J.I. Ottavian, and C.G. Fraga Inhibition of angiotensin converting enzyme activity by flavanol-rich foods J. Agric. Food Chem. 54 2006 229 234 (Pubitemid 43119944)
2. C.F. Ajibola, A.F. Eleyinmi, and R.E. Aluko Kinetics of the inhibition of renin and angiotensin I converting enzyme by polar and non-polar polyphenolic extracts of vernonia amygdalina and gongronema latifolium leaves Plant Foods Hum. Nutr. 66 2011 320 327
3. U. Armato, and G.G. Nussdorfer Tissue culture of rat adult decapsulated adrenal glands. A methodological, ultrastructural and morphometric investigation Z. Zellforsch. Mikrosk. Anat. 135 1972 245 273
4. G.L. Bakris, and M.R. Weir Comparison of dual RAAS blockade and higher-dose RAAS inhibition on nephropathy progression Postgrad. Med. 120 2008 33 42
5. B.W.N. Balasuriya, and H.P.V. Rupasinghe Plant flavonoids as angiotensin converting enzyme inhibitors in regulation of hypertension Funct. Food Health Dis. 5 2011 172 188
6. N. Balasuriya, and H.P. Rupasinghe Antihypertensive properties of flavonoid-rich apple peel extract Food Chem. 135 2012 2320 2325
7. D.A. Calhoun Use of aldosterone antagonists in resistant hypertension Prog. Cardiovasc. Dis. 6 2006 387 396 (Pubitemid 43728142)
8. Y.F. Deng, R.E. Aluko, Q. Jin, Y. Zhang, and L.J. Yuan Inhibitory activities of baicalin against renin and angiotensin-converting enzyme Pharm. Biol. 50 2012 401 406
9. R. Ferrari RAAS inhibition and mortality in hypertension: from pharmacology to clinical evidence J. Clin. Prev. Cardiol. 2 2013 64 72
10. C.A. Gomes, T.G. da Cruz, J.L. Andrade, N. Milhazes, F. Borges, and M.P. Marques Anticancer activity of phenolic acids of natural or synthetic origin: a structure-activity study J. Med. Chem. 46 2003 5395 5401 (Pubitemid 37490372)
11. A.H. Gradman, and R. Kad Renin inhibition in hypertension J. Am. Coll. Cardiol. 51 2008 519 528
12. D. Grunberger, R. Banerjee, K. Eisinger, E.M. Oltz, L. Efros, M. Caldwell, V. Estevez, and K. Nakanishi Preferential cytotoxicity on tumor cells by caffeic acid phenethyl ester isolated from propolis Experientia 44 1988 230 232 (Pubitemid 18066629)
13. L. Heerspink, J. Hiddo, V. Perkovic, and D. de Zeeuw Renal and cardio-protective effects of direct renin inhibition: a systemic literature review J. Hypertens. 27 2009 2321 2331
14. M. Hidalgo, S. Martin-Santamaria, I. Recio, C. Sanchez-Moreno, B. de Pascual-Teresa, G. Rimbach, and S. de Pascual-Teresa Potential anti-inflammatory, anti-adhesive, anti/estrogenic, and angiotensin-converting enzyme inhibitory activities of anthocyanins and their gut metabolites Genes Nutr. 7 2012 295 306
15. W.A. Hsueh, and K. Wyne Renin-angiotensin-aldosterone system in diabetes and hypertension J. Clin. Hypertens. Greenwich 13 2011 224 237
16. R.W. Jiang, K.M. Lau, P.M. Hon, T.C. Mak, K.S. Woo, and K.P. Fung Chemistry and biological activities of caffeic acid derivatives from Salvia miltiorrhiza Curr. Med. Chem. 12 2005 237 246 (Pubitemid 40089836)
17. S. Kumar, P. Prahalathan, and B. Raja Antihypertensive and antioxidant potential of vanillic acid, a phenolic compound in l-NAME-induced hypertensive rats: a dose-dependence study Redox Rep. 16 2011 208 215
18. F. Li, Y. Takahashi, and K. Yamaki Inhibitory effect of catechin-related compounds on renin activity Biomed. Res. 34 2013 167 171
19. P.G. Li, J.W. Xu, K. Ikeda, A. Kobayakawa, Y. Kayano, T. Mitani, T. Ikami, and Y. Yamori Caffeic acid inhibits vascular smooth muscle cell proliferation induced by angiotensin II in stroke-prone spontaneously hypertensive rats Hypertens. Res. 4 2005 369 377 (Pubitemid 40895060)
20. T.K. Ma, K.K. Kam, B.P. Yan, and Y.Y. Lam Renin-angiotensin-aldosterone system blockade for cardiovascular diseases: current status Br. J. Pharmacol. 160 2010 1273 1292
21. H. Makani, S. Bangalore, K.A. Desouza, A. Shah, and F.H. Messerli Efficacy and safety of dual blockade of the renin-angiotensin system: meta-analysis of randomised trials Br. Med. J. 346 2013 1 15
22. J.J. McMurray, B. Pitt, R. Latini, A.P. Maggioni, S.D. Solomon, D.L. Keefe, J. Ford, A. Verma, and J. Lewsey Aliskiren Observation of Heart Failure Treatment (ALOFT) investigators. Effects of the oral direct renin inhibitor aliskiren in patients with symptomatic heart failure Circ. Heart Fail. 1 2008 17 24
23. S. Ohno, S. Shinoda, S. Toyoshima, H. Nakazawa, T. Makino, and S. Nakajin Effects of flavonoid phytochemicals on cortisol production and on activities of steroidogenic enzymes in human adrenocortical H295R cells J. Steroid Biochem. Mol. Biol. 80 2002 355 363 (Pubitemid 34304158)
24. Y. Ohsaki, H. Shirakawa, T. Koseki, and M. Komai Novel effects of a single administration of ferulic acid on the regulation of blood pressure and the hepatic lipid metabolic profile in stroke-prone spontaneously hypertensive rats J. Agric. Food Chem. 56 2008 2825 2830 (Pubitemid 351685231)
25. H. Peng, O.A. Carretero, N. Vuljaj, T.D. Liao, A. Motivala, E.L. Peterson, and N.E. Rhaleb Angiotensin-converting enzyme inhibitors: a new mechanism of action Circulation 16 2005 2436 2445 (Pubitemid 41504493)
26. F. Perez-Vizcaino, J. Duarte, R. Jimenez, C. Santos-Buelga, and A. Osuna Antihypertensive effects of the flavonoid quercetin Pharmacol. Rep. 61 2009 67 75
27. R.H. Pichler, and I.H. deBoer Dual renin-angiotensin-aldosterone system blockade for diabetic kidney disease Curr. Diab. Rep. 4 2010 297 305
28. J.T. Sanderson, H. Clabault, C. Patton, G. Lassalle-Claux, J. Jean-François, A.F. Paré, M.J.G. Hébert, M.E. Surette, and M. Touaibia Antiproliferative, antiandrogenic and cytotoxic effects of novel caffeic acid derivatives in LNCaP human androgen-dependent prostate cancer cells Bioorg. Med. Chem. 21 2013 7182 7193
29. A. Suzuki, N. Yamamoto, H. Jokura, M. Yamamoto, A. Fujii, I. Tokimitsu, and I. Saito Chlorogenic acid attenuates hypertension and improves endothelial function in spontaneously hypertensive rats J. Hypertens. 6 2006 1075 1082
30. S. Takahashi, K. Hori, M. Hokari, T. Gotoh, and T. Sugiyama Inhibition of human renin activity by saponins Biomed. Res. 31 2010 155 159
31. S. Takahashi, K. Hori, M. Shinbo, K. Hiwatashi, T. Gotoh, and S. Yamada Isolation of human renin inhibitor from soybean: soyasaponin I is the novel human renin inhibitor in soybean Biosci. Biotechnol. Biochem. 72 2008 3232 3236
32. Y. Zhao, J. Wang, O. Ballevre, H. Luo, and W. Zhang Antihypertensive effects and mechanisms of chlorogenic acids Hypertens. Res. 4 2011 370 374